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DEAR EDITORS
A public heath problem, osteoporosis, is recog-
nized as the prevalent disease, and mainly causes 
for impairment and loss mass of bone. It closely 
related the balance between bone formation by 
osteoblasts and resorption by osteoclasts during the 
remodeling cycle of bone.1,2 Hence, pharmaceutical 
therapies are looking for the potential agents to 
stimulate osteoblastic bone formation, as well as 
inhibit osteoclastic processes.3 
In Vietnamese traditional medicine, the combi-
nation of the three species, including Dillenia Indica 
(local name “So”), Schefflera racemosa (local name 
“May tang”), Adiantum raddianum (local name “Cut 
nich”), were widely used as a herbal drug of osteoar-
thritis by several ethnic minorities in the mountain-
ous areas of Laocai-Vietnam. However, up to now, no 
studies improve the roles of these crucial medicinal 
herbal plants. In current paper, we set out to investi-
gate the effects of Vietnamese drug formulations of 
three plants on the proliferation and differentiation 
of pre-osteoblastic MC3T3-E1 cells through golden 
criteria, including cell viability, alkaline phospha-
tase activity (ALP), collagen content, and miner-
alization (calcium deposition). The dried leaves of 
these herbal plants were used as materials, whereas 
ultilizing water-ethanol (1:1, v/v) as a solvent for 
extraction. According to tradditional uses, we herein 
proposed the preparation of three drug formulations 
CT1-CT3, followed by the material rates, comprising 
formulation CT1 (3 : 1 : 1, D. Indica : S. racemosa : A. 
raddianum), formulation CT2 (2 : 1 : 1, respectively), 
formulation CT3 (1 : 1 : 1, respectively). The osteo-
blastic protocols were performed as described by.4,5
The fluctuation of viablity of pre-osteoblastic 
MC3T3-E1 cells cultured with or without the 
presence of three formulations were displayed in 
Figure 1A. Data clearly revealed that, at the concen-
trations 50 and 100 µg/mL and 3 days incubation, 
only CT2 increased while the remainders failed 
to do so. Therefore, The formulation CT2 can be 
claimed responsible for next steps. A biochemical 
method, alkaline phosphatase activity, can be seen 
as a obsteoblast phenotype marker, which provided 
quantitative information for the initial differen-
tion.4,6 At the concentrations 50 and 100 µg/mL, 
the drug formulation CT2 significantly promoted 
the increases of ALP activity up to 7.5 and 20% 
after 7 days, respectiely, as compared to that of 
the control (Table 1). Collagen acted as a predom-
inant product in bone cell during the osteoblastic 
differentiation.2 The effects of CT2 on the synthetic 
collagen were investigated, using Sirius red based 
colorimetric experiment. As shown in Table 1, 
accounting for 6 and 25% in the accumulation of 
collagen was induced by this drug formulation at 
the corresponding concentrations of 50 and 100 
µg/mL and after 10 days treatment. Histochemical 
analysis also confirmed that, under two concen-
tration conditions, pre-osteoblastic MC3T3-E1 
cells took higher colors than that of untreat group 
(Figure 1B). During the osteoblastic differentiation, 
calcium accumulated in the matrix and cell layer of 
pre-osteoblastic MC3T3-E1 cells, the observation 
of mineralization was normally assessed by Alirazin 
red staining.2,4,5 After 15 days treament, the formu-
lation CT2 (50 and 100 µg/mL) notably increased 
the mineralization content of respective 14 and 
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Table 1  Effects of drug formulation CT2 (50 and 100 µg/mL) on ALP activity, collagen 
content, and mineralization of MC3T3-E1; Data are expressed as mean ±  
SEM (n = 3), *P < 0.05, **P < 0.01 versus control (only MC3T3-E1)
Concentration (mg/µL) ALP activity (%) Collagen content (%) Mineralization (%)
100 119.70 ± 3.94** 124,55 ± 6.74** 128.65 ± 5.02**
50 107.49 ± 0.61* 105,83 ± 5.56 114.38 ± 2.74*
0 100.00 ± 0.94 100.00 ± 0.85 100.00 ± 2.89
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29%, especially the bright red color was observed at 
100 µg/mL (Table 1 and Figure 1C).
Taken together, at concentration 100 µg/mL, 
Vietnamese combination drug of three plants 
(2 : 1  : 1, D. Indica : S. racemosa : A. raddianum) 
evidently generated the prospective values in the 
treatment of bone related diseases. Therefore, 
extensive researches in either further biological 
experiments or phytochemical investigations are 
expected.
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Figure 1A  Effects of drug formulation CT1-CT3 (50 , 100 and 200 µg/mL) 
on viability of MC3T3-E1; Data are expressed as mean ± SEM 
(n = 3), *P < 0.05 versus control (only MC3T3-E1)
Figure 1B  Sirius red staining: a) only MC3T3-E1, b) MC3T3-E1 + CT2 
(50 µg/mL), c) MC3T3-E1 + CT2 (100 µg/mL) 
Figure 1C  Alizarin red staining: a) only MC3T3-E1; b) MC3T3-E1 + CT2 
(50 µg/mL); c) MC3T3-E1 + CT2 (100 µg/mL)
